Research in the journal Infection Control & Hospital Epidemiology showed health care-acquired bloodstream infections in pediatric patients have a significant impact on health care costs, length of stay and mortality and are associated with the highest number of preventable deaths among health care-associated infections. Costs for HA-BSIs range from $960 million to $18.2 billion annually, the researchers said.